Current practice regarding seizure prophylaxis in aneurysmal subarachnoid hemorrhage across academic centers

Journal of NeuroInterventional Surgery

Volumn 7, Issue 2, 2015, Pages 146-149

  Dewan, Michael C ^a   Mocco, J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; PHENYTOIN; ANTICONVULSIVE AGENT;

ANTICONVULSANT THERAPY; ARTICLE; CLINICAL PRACTICE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; ELECTROENCEPHALOGRAPHY; HEALTH CARE SURVEY; HUMAN; PROPHYLAXIS; RISK ASSESSMENT; SEIZURE; SUBARACHNOID HEMORRHAGE; TREATMENT DURATION; TREATMENT OUTCOME; CLINICAL TRIAL; COMPLICATION; INFORMATION PROCESSING; INTRACRANIAL ANEURYSM; MULTICENTER STUDY; PRE-EXPOSURE PROPHYLAXIS; PROCEDURES; SEIZURES; TRENDS;

ANTICONVULSANTS; DATA COLLECTION; HUMANS; INTRACRANIAL ANEURYSM; PRE-EXPOSURE PROPHYLAXIS; SEIZURES; SUBARACHNOID HEMORRHAGE;

EID: 84921031710     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2013-011075     Document Type: Article

References (19)

1. Kvam DA, Loftus CM, Copeland B, et al. Seizures during the immediate postoperative period. Neurosurgery 1983;12: 14-17.
2. North JB, Penhall RK, Hanieh A, et al. Phenytoin and postoperative epilepsy. A double-blind study. J Neurosurg 1983;58: 672-7.
3. Butzkueven H, Evans AH, Pitman A, et al. Onset seizures independently predict poor outcome after subarachnoid hemorrhage. Neurology 2000;55: 1315-20.
4. Dennis LJ, Claassen J, Hirsch LJ, et al. Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery 2002;51: 1136-43.
5. Little AS, Kerrigan JF, McDougall CG, et al. Nonconvulsive status epilepticus in patients suffering spontaneous subarachnoid hemorrhage. J Neurosurg 2007;106: 805-11.
6. Deutschman CS, Haines SJ. Anticonvulsant prophylaxis in neurological surgery. Neurosurgery 1985;17: 510-17.
7. Rhoney DH, Tipps LB, Murry KR, et al. Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage. Neurology 2000;55: 258-65.
8. Choi K-S, Chun H-J, Yi H-J, et al. Seizures and epilepsy following aneurysmal subarachnoid hemorrhage: Incidence and risk factors. J Korean Neurosurg Soc 2009;46: 93-8.
9. Naidech AM, Kreiter KT, Janjua N, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 2005;36: 583-7.
10. Carreno M. Levetiracetam. Drugs Today 2007;43: 769-94.
11. Nau KM, Divertie GD, Valentino AK, et al. Safety and efficacy of levetiracetam for critically ill patients with seizures. Neurocrit Care 2009;11: 34-7.
12. Shah D, Husain AM. Utility of levetiracetam in patients with subarachnoid hemorrhage. Seizure 2009;18: 676-9.
13. Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012;43: 1711-37.
14. Rosengart AJ, Huo JD, Tolentino J, et al. Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg 2007;107: 253-60.
15. Usami K, Saito N. Prophylactic anticonvulsants after subarachnoid hemorrhage. World Neurosurg 2011;75: 214.
16. Sundaram MB, Chow F. Seizures associated with spontaneous subarachnoid hemorrhage. Can J Neurol Sci 1986;13: 229-31.
17. Hovinga CA. Levetiracetam: A novel antiepileptic drug. Pharmacotherapy 2001;21: 1375-88.
18. Szaflarski JP, Sangha KS, Lindsell CJ, et al. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care 2010;12: 165-72.
19. Murphy-Human T, Welch E, Zipfel G, et al. Comparison of short-duration levetiracetam with extended-course phenytoin for seizure prophylaxis after subarachnoid hemorrhage. World Neurosurg 2011;75: 269-74.